Posterior reversible encephalopathy syndrome in childhood cancer

P de Laat1, M L Te Winkel, A S Devos

  • 1Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children’s Hospital, University Medical Center, Rotterdam, The Netherlands.

Insights

Posterior reversible encephalopathy syndrome (PRES) in children with cancer is often triggered by hypertension and presents with seizures. While symptoms typically resolve, some patients may experience lasting neurological issues.

Area of Science:

  • Neurology
  • Pediatric Oncology
  • Radiology

Background:

  • Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by seizures, headaches, altered mental status, cortical blindness, and transient MRI lesions.
  • PRES is increasingly recognized in pediatric cancer patients, often associated with specific treatments and underlying malignancies.

Purpose of the Study:

  • To investigate the incidence, clinical presentation, and outcomes of PRES in children undergoing cancer treatment.
  • To identify potential triggers and associated factors of PRES in this vulnerable population.

Main Methods:

  • A retrospective review of seven childhood cancer patients with PRES was conducted.
  • A comprehensive literature search identified and analyzed 49 additional well-documented cases of childhood cancer-associated PRES.

Main Results:

  • Fifty-six cases of pediatric cancer-associated PRES were identified, with a mean age of onset at 9 years.
  • Acute lymphoblastic leukemia was the most common primary diagnosis (31 cases), followed by solid tumors (13 cases).
  • Hypertension (49 patients) was the most frequent trigger, and seizures (50 patients) were the most common symptom. Approximately 86% of patients showed reversible clinical and radiological symptoms.

Conclusions:

  • PRES occurs in children with both leukemia and solid tumors, not exclusively in leukemia patients.
  • Hypertension is a critical factor in PRES development during childhood cancer therapy.
  • While most cases resolve, a small percentage (around 10%) may have persistent neurological deficits.
Abstract

Related Concept Videos

Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...